The William Harvey Research Institute (WHRI) is a world leading Pharmacological Centre with a vibrant, multidisciplinary scientific environment devoted to therapeutic innovation in cardiovascular, endocrine and inflammatory diseases.

Cutting edge translational research at WHRI, alongside the therapeutic innovation spirit of the Institute and its members, rewarded today by a significant deal between Pfizer, MRC Technology and QMUL. More info at link

350 scientists and clinicians from 44 Nations Worldwide with 65% staff rated world-class or internationally leading in RAE 2008.

Top paper in Worldwide Science in 2007, top 10 papers in cardiovascular research in 2009 and 2011.

12 BHF, Wellcome, NIHR, MRC, The Gates Foundation and EU Programmes.

NIHR Cardiovascular Biomedical Research Unit (£12 million since 2008).

Joint Cardiovascular Programme with UCL Institute of Cardiovascular Sciences.

Arthritis Research UK Experimental Arthritis Treatment Centre (2012).

For more information,visit www.whri.qmul.ac.uk.